| Trial ID: | L1399 |
| Source ID: | NCT02476526
|
| Associated Drug: |
Low Volume Iso-Osmolar Non-Ionic Radio Contrast Medium
|
| Title: |
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Pulmonary Embolism|Renal Artery Stenosis|Pulmonary Cancer
|
| Interventions: |
DRUG: Low Volume iso-osmolar non-ionic radio contrast medium|DRUG: Acetylcysteine Inhalation|DRUG: Sodium Bicarbonate Solution|PROCEDURE: 64-MDCT Scanning
|
| Outcome Measures: |
Primary: Peak Serum Creatinine Level, The peak serum creatinine increase over baseline within 72 hours after intervention is the outcome variable. This variable is used for comparison between two groups, as well as for safety monitoring in the intervention group (25% increase is the upper threshold), Up to 72 hours after intervention |
|
| Sponsor/Collaborators: |
Sponsor: VA Greater Los Angeles Healthcare System | Collaborators: General Electric
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2008-09
|
| Completion Date: |
2017-11-20
|
| Results First Posted: |
|
| Last Update Posted: |
2017-11-28
|
| Locations: |
VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02476526
|
